Results for tag: "Anaplastic Astrocytoma Drug"

Anaplastic Astrocytoma (AA) is a type of brain cancer that is typically treated with a combination of surgery, radiation therapy, and chemotherapy. Drug treatments for AA are typically targeted therapies, which are designed to specifically target the cancer cells while leaving healthy cells unharmed. These drugs are often used in combination with other treatments to improve the effectiveness of the therapy. Common drugs used to treat AA include temozolomide, lomustine, and bevacizumab. Targeted therapies are often used in combination with other treatments to improve the effectiveness of the therapy. For example, temozolomide is often used in combination with radiation therapy to improve the effectiveness of the treatment. Additionally, bevacizumab is often used in combination with chemotherapy to improve the effectiveness of the treatment. The Anaplastic Astrocytoma Drug market is a rapidly growing market, with many companies developing new drugs and treatments for AA. Companies in the market include Novartis, Merck, Pfizer, and Roche. Show Less Read more